BenevolentAI | Results Presentation Deck | 23 slides

BenevolentAI · 2024-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

23
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · AttentionLoop · Golden Circle
02
other
Open slide detailBeat · AttentionLoop · Golden Circle
03
introduce_nominees
Open slide detailBeat · AttentionLoop · Golden Circle
04
The slide uses a timeline-like visual structure to list key company highlights.summarize
Open slide detailBeat · AttentionLoop · Golden Circle
05
The slide uses a three-column layout to categorize business activities into 'Established Business' and 'New Expansion Opportunity'.present_solution
Open slide detailBeat · NeedLoop · Golden Circle
06
The slide uses a list-based structure to showcase proof points of the platform's efficacy.present_framework
Open slide detailBeat · NeedLoop · Golden Circle
07
summarize
Open slide detailBeat · NeedLoop · Golden Circle
08
The slide uses a process flow diagram to illustrate how data ingestion feeds into a knowledge graph, which then powers specific AI-driven drug discovery applicapresent_solution
Open slide detailBeat · SatisfactionLoop · Golden Circle
09
Slide 9 of a presentation deck.illustrate_case
Open slide detailBeat · SatisfactionLoop · Golden Circle
10
Timeline-style list on the left, thematic icons and bullet points on the right.establish_context
Open slide detailBeat · SatisfactionLoop · Golden Circle
11
The slide uses a Gantt-style visualization to show the status of 5 specific drug development programs.analyze_data
Open slide detailBeat · SatisfactionLoop · Golden Circle
12
present_solution
Open slide detailBeat · SatisfactionLoop · Golden Circle
13
The slide uses a two-column layout: the left side focuses on the disease burden and market opportunity, while the right side details the therapeutic solution andiagnose_problem
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
14
The slide outlines the study design for a Phase Ia trial and explains why safety data is critical for the PDE10 inhibitor class.summarize
Open slide detailBeat · SatisfactionLoop · Cost Of Inaction
15
The slide presents a standard financial performance review with a bulleted list of key drivers and a supporting data table.analyze_data
Open slide detailBeat · SatisfactionLoop · Golden Circle
16
summarize
Open slide detailBeat · SatisfactionLoop · Golden Circle
17
appendix
Open slide detailBeat · VisualizationLoop · Golden Circle
18
Slide includes both corporate governance (Board/ELT) and investor relations data.other
Open slide detailBeat · VisualizationLoop · Golden Circle
19
The table includes detailed breakdowns of R&D and administrative expenses, including restructuring and share-based payment (SBP) expenses.analyze_data
Open slide detailBeat · VisualizationLoop · Golden Circle
20
Standard financial reporting table.analyze_data
Open slide detailBeat · VisualizationLoop · Golden Circle
21
Standard financial reporting table showing operating, investing, and financing activities.analyze_data
Open slide detailBeat · VisualizationLoop · Golden Circle
22
Includes a process diagram for ex-vivo biopsy treatment and two dose-response curves for IL-6 and IL-8 inhibition.analyze_data
Open slide detailBeat · VisualizationLoop · Golden Circle
23
Neon-style typography on a dark blue background.summarize
Open slide detailBeat · VisualizationLoop · Golden Circle